{"transactions":[{"id":4626163,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":2800,"price":82.365,"value":230622.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $82.28 to $82.53, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1050249,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4626162,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":9900,"price":81.8254,"value":810071.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $81.28 to $82.25 inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1053049,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4626161,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":9300,"price":80.9033,"value":752400.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $80.28 to $81.27, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1062949,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4626160,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":79.6195,"value":159239.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $79.11 to $80.07, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1072249,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4626159,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":78.2284,"value":78228.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.75 to $78.73, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1074249,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":3135,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-03T21:19:42.000Z","date":"2026-09-01","kind":"gift","planned":false,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1075249,"source":{"system":"sec-edgar","filing":"0001610717-26-000396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000396/form4.xml","form_type":"4"}},{"id":672713,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-28T19:22:30.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":492,"price":64.7465,"value":31855.278,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $64.59 to $64.99, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1075349,"source":{"system":"sec-edgar","filing":"0001610717-26-000393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000393/form4.xml","form_type":"4"}},{"id":672712,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-28T19:22:30.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":6494,"price":63.9768,"value":415465.3392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $63.56 to $64.54, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1075841,"source":{"system":"sec-edgar","filing":"0001610717-26-000393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000393/form4.xml","form_type":"4"}},{"id":672711,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-28T19:22:30.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":63.0229,"value":220580.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $62.53 to $63.50, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1082335,"source":{"system":"sec-edgar","filing":"0001610717-26-000393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000393/form4.xml","form_type":"4"}},{"id":674562,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-26T20:46:04.000Z","date":"2026-08-24","kind":"sale","planned":false,"acquired":false,"shares":18545,"price":63.0237,"value":1168774.5165,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.78, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1085835,"source":{"system":"sec-edgar","filing":"0001610717-26-000392","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000392/form4.xml","form_type":"4"}},{"id":677062,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-24T20:16:39.000Z","date":"2026-08-20","kind":"gift","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1104380,"source":{"system":"sec-edgar","filing":"0001610717-26-000386","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000386/form4.xml","form_type":"4"}},{"id":727255,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":1661,"price":36.1646,"value":60069.4006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $35.98 to $36.24, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1108380,"source":{"system":"sec-edgar","filing":"0001610717-26-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/form4.xml","form_type":"4"}},{"id":727254,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":9821,"price":35.3159,"value":346837.4539,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $34.86 to $35.82, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1110041,"source":{"system":"sec-edgar","filing":"0001610717-26-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/form4.xml","form_type":"4"}},{"id":727253,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":9991,"price":34.2815,"value":342506.4665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $33.76 to $34.71, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1119862,"source":{"system":"sec-edgar","filing":"0001610717-26-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/form4.xml","form_type":"4"}},{"id":727252,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":8527,"price":33.289,"value":283855.303,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.75 to $33.74, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1129853,"source":{"system":"sec-edgar","filing":"0001610717-26-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/form4.xml","form_type":"4"}},{"id":761188,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-27T21:57:37.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":10718,"price":24.7092,"value":264833.2056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $24.45 to $24.88, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1138380,"source":{"system":"sec-edgar","filing":"0001610717-26-000164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000164/form4.xml","form_type":"4"}},{"id":761187,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-27T21:57:37.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":18175,"price":24.4415,"value":444224.2625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1149098,"source":{"system":"sec-edgar","filing":"0001610717-26-000164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000164/form4.xml","form_type":"4"}},{"id":806792,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-16T20:07:33.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":24.5568,"value":122784.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $24.49 to $24.70, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1167273,"source":{"system":"sec-edgar","filing":"0001610717-26-000145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000145/form4.xml","form_type":"4"}},{"id":827950,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-25T21:15:13.000Z","date":"2026-03-24","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":19.5223,"value":97611.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $19.49 to $19.59, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1172273,"source":{"system":"sec-edgar","filing":"0001610717-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000134/form4.xml","form_type":"4"}},{"id":827949,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-25T21:15:13.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":19.1297,"value":191297.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.78 to $19.41, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the transfer by the Reporting Person of 13,644 shares of Class A Common Stock to the Y/S Pot Trust on March 3, 2026."}],"balance_after":1177273,"source":{"system":"sec-edgar","filing":"0001610717-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000134/form4.xml","form_type":"4"}},{"id":860518,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:14:12.000Z","date":"2026-03-03","kind":"gift","planned":true,"acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1200917,"source":{"system":"sec-edgar","filing":"0001610717-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000086/form4.xml","form_type":"4"}},{"id":860517,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:14:12.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":1860,"price":23.1781,"value":43111.266,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $23.15 to $23.25, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1203667,"source":{"system":"sec-edgar","filing":"0001610717-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000086/form4.xml","form_type":"4"}},{"id":860516,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:14:12.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":14292,"price":22.669,"value":323985.348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.15 to $23.145, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1205527,"source":{"system":"sec-edgar","filing":"0001610717-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000086/form4.xml","form_type":"4"}},{"id":873352,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-02T21:24:35.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":157895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1219819,"source":{"system":"sec-edgar","filing":"0001610717-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000077/form4.xml","form_type":"4"}},{"id":881333,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:52:57.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":9632,"price":18.5764,"value":178927.8848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1061924,"source":{"system":"sec-edgar","filing":"0001610717-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000070/form4.xml","form_type":"4"}},{"id":943896,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T21:52:55.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":32537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":173600,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":32537},"source":{"system":"sec-edgar","filing":"0001610717-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000003/form4.xml","form_type":"4"}},{"id":943895,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T21:52:55.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":17463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":17463},"source":{"system":"sec-edgar","filing":"0001610717-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000003/form4.xml","form_type":"4"}},{"id":943894,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-01-07T21:52:55.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":1.2,"value":60000.0,"ownership":{"direct":true},"balance_after":1071556,"source":{"system":"sec-edgar","filing":"0001610717-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000003/form4.xml","form_type":"4"}},{"id":988315,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-25T22:23:35.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":13261,"price":18.9983,"value":251936.4563,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1021556,"source":{"system":"sec-edgar","filing":"0001610717-25-000398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000398/form4.xml","form_type":"4"}},{"id":1038980,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-16T20:37:26.000Z","date":"2025-09-12","kind":"gift","planned":false,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1034817,"source":{"system":"sec-edgar","filing":"0001610717-25-000341","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000341/form4.xml","form_type":"4"}},{"id":1055283,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-26T20:15:30.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":9348,"price":13.787,"value":128880.876,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":945892,"source":{"system":"sec-edgar","filing":"0001610717-25-000321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000321/form4.xml","form_type":"4"}},{"id":1114528,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-11T22:31:49.000Z","date":"2025-06-09","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects transfer of 88,955 shares to Sirius Trust and 35,430 shares to Y/S Pot Trust on June 5, 2025."}],"balance_after":955240,"source":{"system":"sec-edgar","filing":"0001610717-25-000199","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000199/form4.xml","form_type":"4"}},{"id":1127161,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-02T21:16:35.000Z","date":"2025-05-29","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1080625,"source":{"system":"sec-edgar","filing":"0001610717-25-000147","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000147/form4.xml","form_type":"4"}},{"id":1132876,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-27T21:08:05.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":9343,"price":8.2993,"value":77540.3599,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1083625,"source":{"system":"sec-edgar","filing":"0001610717-25-000144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000144/form4.xml","form_type":"4"}},{"id":1196656,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-19T21:35:44.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":171428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1092968,"source":{"system":"sec-edgar","filing":"0001610717-25-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000075/form4.xml","form_type":"4"}},{"id":1225900,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T23:50:19.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, originally for 300,000 shares, of which 282,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021."}],"balance_after":17463,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001610717-25-000049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000049/form4.xml","form_type":"4"}},{"id":1225899,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:50:19.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":1.2,"value":60000.0,"ownership":{"direct":true},"balance_after":921540,"source":{"system":"sec-edgar","filing":"0001610717-25-000049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000049/form4.xml","form_type":"4"}},{"id":1225898,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:50:19.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":7942,"price":10.6262,"value":84393.2804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on September 12, 2024 and terminated effective March 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.415 to $10.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":871540,"source":{"system":"sec-edgar","filing":"0001610717-25-000049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000049/form4.xml","form_type":"4"}},{"id":1242344,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-26T22:42:46.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":5092,"price":11.0656,"value":56346.0352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":879482,"source":{"system":"sec-edgar","filing":"0001610717-25-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000036/form4.xml","form_type":"4"}},{"id":1322531,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-24T01:29:36.000Z","date":"2024-12-23","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, originally for 300,000 shares, of which 232,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021."}],"balance_after":67463,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001610717-24-000554","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000554/form4.xml","form_type":"4"}},{"id":1322530,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-24T01:29:36.000Z","date":"2024-12-23","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":1.2,"value":14400.0,"ownership":{"direct":true},"balance_after":884574,"source":{"system":"sec-edgar","filing":"0001610717-24-000554","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000554/form4.xml","form_type":"4"}},{"id":1352304,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-25T21:53:14.000Z","date":"2024-11-22","kind":"sale","planned":false,"acquired":false,"shares":6693,"price":13.6878,"value":91612.4454,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":872574,"source":{"system":"sec-edgar","filing":"0001610717-24-000530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000530/form4.xml","form_type":"4"}},{"id":1352303,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-25T21:53:14.000Z","date":"2024-11-21","kind":"gift","planned":false,"acquired":false,"shares":1850,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":879267,"source":{"system":"sec-edgar","filing":"0001610717-24-000530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000530/form4.xml","form_type":"4"}},{"id":1361267,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-18T21:43:55.000Z","date":"2024-11-14","kind":"gift","planned":false,"acquired":false,"shares":1350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":881117,"source":{"system":"sec-edgar","filing":"0001610717-24-000524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000524/form4.xml","form_type":"4"}},{"id":1422935,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-26T21:05:19.000Z","date":"2024-08-22","kind":"sale","planned":false,"acquired":false,"shares":6749,"price":22.5297,"value":152052.9453,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":882467,"source":{"system":"sec-edgar","filing":"0001610717-24-000455","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000455/form4.xml","form_type":"4"}},{"id":1496254,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-31T20:06:12.000Z","date":"2024-05-29","kind":"gift","planned":false,"acquired":false,"shares":425,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":889216,"source":{"system":"sec-edgar","filing":"0001610717-24-000271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000271/form4.xml","form_type":"4"}},{"id":1503172,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-23T23:53:05.000Z","date":"2024-05-22","kind":"sale","planned":false,"acquired":false,"shares":4877,"price":24.3036,"value":118528.6572,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":889641,"source":{"system":"sec-edgar","filing":"0001610717-24-000258","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000258/form4.xml","form_type":"4"}},{"id":1561633,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-25T21:17:26.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":88854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2024, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":894518,"source":{"system":"sec-edgar","filing":"0001610717-24-000186","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000186/form4.xml","form_type":"4"}},{"id":1571779,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-18T23:02:46.000Z","date":"2024-03-14","kind":"gift","planned":false,"acquired":false,"shares":1086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects transfer of 29,900 shares to Y/S Descendants' Trust and 6,250 shares to Y/S Pot Trust on March 14, 2024."}],"balance_after":805664,"source":{"system":"sec-edgar","filing":"0001610717-24-000163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000163/form4.xml","form_type":"4"}},{"id":1590697,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-06T21:12:06.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":4660,"price":43.9959,"value":205020.894,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $43.9600 to $44.0401. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":842900,"source":{"system":"sec-edgar","filing":"0001610717-24-000135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000135/form4.xml","form_type":"4"}},{"id":1618521,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-26T21:13:36.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":2821,"price":46.3443,"value":130737.2703,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":847560,"source":{"system":"sec-edgar","filing":"0001610717-24-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000092/form4.xml","form_type":"4"}},{"id":1632448,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-20T21:20:30.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":49.4306,"value":84032.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on September 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $49.10 to $49.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":850381,"source":{"system":"sec-edgar","filing":"0001610717-24-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000071/form4.xml","form_type":"4"}},{"id":1632447,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-20T21:20:30.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":3300,"price":48.5758,"value":160300.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on September 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $48.08 to $49.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":852081,"source":{"system":"sec-edgar","filing":"0001610717-24-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000071/form4.xml","form_type":"4"}},{"id":1645254,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-13T21:56:40.000Z","date":"2024-02-09","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":49.5301,"value":49530.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on September 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $49.50 to $49.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":855381,"source":{"system":"sec-edgar","filing":"0001610717-24-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000058/form4.xml","form_type":"4"}},{"id":1675984,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T21:49:13.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":1035,"price":45.6467,"value":47244.3345,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on September 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $45.49 to $45.82. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":856381,"source":{"system":"sec-edgar","filing":"0001610717-24-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000030/form4.xml","form_type":"4"}},{"id":1675983,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T21:49:13.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":2965,"price":45.0967,"value":133711.7155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on September 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $44.48 to $45.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":857416,"source":{"system":"sec-edgar","filing":"0001610717-24-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000030/form4.xml","form_type":"4"}},{"id":1697700,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T21:17:40.000Z","date":"2023-12-27","kind":"exercise","planned":false,"acquired":false,"shares":14935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, originally for 300,000 shares, of which 220,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The balance for this grant has been updated from the filing made on December 28, 2021 to reflect the correct amount."}],"balance_after":79463,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":14935},"source":{"system":"sec-edgar","filing":"0001610717-23-000426","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000426/form4.xml","form_type":"4"}},{"id":1697699,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-29T21:17:40.000Z","date":"2023-12-27","kind":"exercise","planned":false,"acquired":true,"shares":14935,"price":1.2,"value":17922.0,"ownership":{"direct":true},"balance_after":860381,"source":{"system":"sec-edgar","filing":"0001610717-23-000426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000426/form4.xml","form_type":"4"}},{"id":1706580,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-18T22:43:14.000Z","date":"2023-12-14","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":55.1465,"value":93749.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $54.73 to $55.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":845446,"source":{"system":"sec-edgar","filing":"0001610717-23-000402","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000402/form4.xml","form_type":"4"}},{"id":1706579,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-18T22:43:14.000Z","date":"2023-12-14","kind":"sale","planned":true,"acquired":false,"shares":300,"price":54.3867,"value":16316.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $53.715 to $54.555. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":847146,"source":{"system":"sec-edgar","filing":"0001610717-23-000402","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000402/form4.xml","form_type":"4"}},{"id":1729315,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-27T23:15:09.000Z","date":"2023-11-24","kind":"sale","planned":false,"acquired":false,"shares":3723,"price":43.715,"value":162750.945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $43.65 to $43.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":847446,"source":{"system":"sec-edgar","filing":"0001610717-23-000364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000364/form4.xml","form_type":"4"}},{"id":1729314,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-27T23:15:09.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":3757,"price":43.3367,"value":162815.9819,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":851169,"source":{"system":"sec-edgar","filing":"0001610717-23-000364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000364/form4.xml","form_type":"4"}},{"id":1738563,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-16T21:22:44.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":39.5203,"value":79040.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $39.50 to $39.575. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":854926,"source":{"system":"sec-edgar","filing":"0001610717-23-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000358/form4.xml","form_type":"4"}},{"id":1757915,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-18T20:33:20.000Z","date":"2023-10-17","kind":"sale","planned":true,"acquired":false,"shares":1979,"price":39.5084,"value":78187.1236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $39.50 to $39.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":856926,"source":{"system":"sec-edgar","filing":"0001610717-23-000312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000312/form4.xml","form_type":"4"}},{"id":1757914,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-18T20:33:20.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":21,"price":39.5,"value":829.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."}],"balance_after":858905,"source":{"system":"sec-edgar","filing":"0001610717-23-000312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000312/form4.xml","form_type":"4"}},{"id":1778601,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-18T20:43:15.000Z","date":"2023-09-14","kind":"gift","planned":true,"acquired":false,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":858926,"source":{"system":"sec-edgar","filing":"0001610717-23-000280","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000280/form4.xml","form_type":"4"}},{"id":1778600,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-18T20:43:15.000Z","date":"2023-09-14","kind":"sale","planned":true,"acquired":false,"shares":80,"price":49.82,"value":3985.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $49.78 to $49.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":862093,"source":{"system":"sec-edgar","filing":"0001610717-23-000280","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000280/form4.xml","form_type":"4"}},{"id":1778599,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-18T20:43:15.000Z","date":"2023-09-14","kind":"sale","planned":true,"acquired":false,"shares":1920,"price":49.3509,"value":94753.728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $48.78 to $49.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":862173,"source":{"system":"sec-edgar","filing":"0001610717-23-000280","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000280/form4.xml","form_type":"4"}},{"id":1797357,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-24T21:11:19.000Z","date":"2023-08-22","kind":"sale","planned":false,"acquired":false,"shares":3757,"price":45.7811,"value":171999.5927,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":864093,"source":{"system":"sec-edgar","filing":"0001610717-23-000238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000238/form4.xml","form_type":"4"}},{"id":1805082,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-16T21:11:13.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":17,"price":50.42,"value":857.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."}],"balance_after":867850,"source":{"system":"sec-edgar","filing":"0001610717-23-000228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000228/form4.xml","form_type":"4"}},{"id":1805081,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-16T21:11:13.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":1983,"price":50.1033,"value":99354.8439,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $49.40 to $50.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":867867,"source":{"system":"sec-edgar","filing":"0001610717-23-000228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000228/form4.xml","form_type":"4"}},{"id":1824638,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-21T21:32:53.000Z","date":"2023-07-19","kind":"exercise","planned":true,"acquired":false,"shares":20845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"All of the shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":32478,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":20845},"source":{"system":"sec-edgar","filing":"0001610717-23-000215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000215/form4.xml","form_type":"4"}},{"id":1824637,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-21T21:32:53.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":60.0272,"value":2401088.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $60.00 to $60.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":869850,"source":{"system":"sec-edgar","filing":"0001610717-23-000215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000215/form4.xml","form_type":"4"}},{"id":1824636,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-21T21:32:53.000Z","date":"2023-07-19","kind":"exercise","planned":true,"acquired":true,"shares":20845,"price":5.04,"value":105058.8,"ownership":{"direct":true},"balance_after":909850,"source":{"system":"sec-edgar","filing":"0001610717-23-000215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000215/form4.xml","form_type":"4"}},{"id":1827551,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-18T22:26:55.000Z","date":"2023-07-14","kind":"sale","planned":true,"acquired":false,"shares":1149,"price":58.3674,"value":67064.1426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $58.02 to $58.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":889005,"source":{"system":"sec-edgar","filing":"0001610717-23-000205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000205/form4.xml","form_type":"4"}},{"id":1827550,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-18T22:26:55.000Z","date":"2023-07-14","kind":"sale","planned":true,"acquired":false,"shares":851,"price":57.6102,"value":49026.2802,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $57.02 to $58.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":890154,"source":{"system":"sec-edgar","filing":"0001610717-23-000205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000205/form4.xml","form_type":"4"}},{"id":1851209,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-16T21:37:43.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":51,"price":59.15,"value":3016.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $59.05 to $59.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":891005,"source":{"system":"sec-edgar","filing":"0001610717-23-000171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000171/form4.xml","form_type":"4"}},{"id":1851208,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-16T21:37:43.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":1209,"price":58.5262,"value":70758.1758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $58.05 to $59.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":891056,"source":{"system":"sec-edgar","filing":"0001610717-23-000171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000171/form4.xml","form_type":"4"}},{"id":1851207,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-16T21:37:43.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":740,"price":57.5038,"value":42552.812,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $57.03 to $58.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":892265,"source":{"system":"sec-edgar","filing":"0001610717-23-000171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000171/form4.xml","form_type":"4"}},{"id":1851206,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-16T21:37:43.000Z","date":"2023-06-14","kind":"gift","planned":true,"acquired":false,"shares":185,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":893005,"source":{"system":"sec-edgar","filing":"0001610717-23-000171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000171/form4.xml","form_type":"4"}},{"id":1880667,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-23T23:51:09.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":2068,"price":55.0613,"value":113866.7684,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":893190,"source":{"system":"sec-edgar","filing":"0001610717-23-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000062/form4.xml","form_type":"4"}},{"id":1880666,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-23T23:51:09.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":534,"price":55.064,"value":29404.176,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":895258,"source":{"system":"sec-edgar","filing":"0001610717-23-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000062/form4.xml","form_type":"4"}},{"id":1880665,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-23T23:51:09.000Z","date":"2023-05-19","kind":"gift","planned":false,"acquired":false,"shares":460,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee."}],"balance_after":27,"source":{"system":"sec-edgar","filing":"0001610717-23-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000062/form4.xml","form_type":"4"}},{"id":1888279,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-17T20:35:07.000Z","date":"2023-05-15","kind":"sale","planned":true,"acquired":false,"shares":1506,"price":53.5652,"value":80669.1912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $53.08 to $53.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":895792,"source":{"system":"sec-edgar","filing":"0001610717-23-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000045/form4.xml","form_type":"4"}},{"id":1888278,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-17T20:35:07.000Z","date":"2023-05-15","kind":"sale","planned":true,"acquired":false,"shares":494,"price":52.6971,"value":26032.3674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $52.05 to $53.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":897298,"source":{"system":"sec-edgar","filing":"0001610717-23-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000045/form4.xml","form_type":"4"}},{"id":1917780,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-18T20:39:47.000Z","date":"2023-04-14","kind":"sale","planned":true,"acquired":false,"shares":76,"price":55.2799,"value":4201.2724,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $55.15 to $55.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":897792,"source":{"system":"sec-edgar","filing":"0001610717-23-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000013/form4.xml","form_type":"4"}},{"id":1917779,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-18T20:39:47.000Z","date":"2023-04-14","kind":"sale","planned":true,"acquired":false,"shares":283,"price":54.6367,"value":15462.1861,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $54.13 to $55.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":897868,"source":{"system":"sec-edgar","filing":"0001610717-23-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000013/form4.xml","form_type":"4"}},{"id":1917778,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-18T20:39:47.000Z","date":"2023-04-14","kind":"sale","planned":true,"acquired":false,"shares":1641,"price":53.6115,"value":87976.4715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $53.12 to $54.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":898151,"source":{"system":"sec-edgar","filing":"0001610717-23-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000013/form4.xml","form_type":"4"}},{"id":1939918,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Performance - based Restricted Stock Units","published_at":"2023-03-23T22:25:43.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":72773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":72773,"derivative":{"expiration_date":"2028-04-01","underlying":"Class A Common Stock","underlying_shares":72773},"source":{"system":"sec-edgar","filing":"0001140361-23-013506","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013506/form4.xml","form_type":"4"}},{"id":1939917,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-23T22:25:43.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":72773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a  service provider through each such date."}],"balance_after":72773,"derivative":{"exercise_price":50.1,"expiration_date":"2033-03-21","underlying":"Class A Common Stock","underlying_shares":72773},"source":{"system":"sec-edgar","filing":"0001140361-23-013506","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013506/form4.xml","form_type":"4"}},{"id":1939916,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-23T22:25:43.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":36387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":899792,"source":{"system":"sec-edgar","filing":"0001140361-23-013506","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013506/form4.xml","form_type":"4"}},{"id":1949492,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-16T20:27:54.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":303,"price":49.2808,"value":14932.0824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $49.15 to $49.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":863405,"source":{"system":"sec-edgar","filing":"0001567619-23-005183","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761923005183/doc1.xml","form_type":"4"}},{"id":1949491,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-16T20:27:54.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":1697,"price":48.806,"value":82823.782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $48.15 to $49.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excludes 870 shares transferred to Sirius Trust, 6,050 shares transferred to Y/S Pot Trust and 37,390 shares transferred to the Y/S Descendants' Trust, on March 11, 2023."}],"balance_after":863708,"source":{"system":"sec-edgar","filing":"0001567619-23-005183","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761923005183/doc1.xml","form_type":"4"}},{"id":1960424,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-09T21:43:16.000Z","date":"2023-03-07","kind":"gift","acquired":false,"shares":260,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee."}],"balance_after":487,"source":{"system":"sec-edgar","filing":"0001567619-23-004744","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761923004744/doc1.xml","form_type":"4"}},{"id":1992226,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T22:51:14.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":1941,"price":47.7533,"value":92689.1553,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":909715,"source":{"system":"sec-edgar","filing":"0001567619-23-003779","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761923003779/doc1.xml","form_type":"4"}},{"id":2086082,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-14T21:35:13.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, originally for 300,000 shares, of which 261,965 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":38035,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001567619-22-021571","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922021571/doc1.xml","form_type":"4"}},{"id":2086081,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:35:13.000Z","date":"2022-12-13","kind":"gift","acquired":false,"shares":1740,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee."}],"balance_after":747,"source":{"system":"sec-edgar","filing":"0001567619-22-021571","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922021571/doc1.xml","form_type":"4"}},{"id":2086080,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:35:13.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":3000,"price":1.2,"value":3600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes 870 shares transferred to Sirius Trust, 9,400 shares transferred to Y/S Pot Trust and 56,000 shares transferred to the Y/S Descendants' Trust, on December 13, 2022."}],"balance_after":911656,"source":{"system":"sec-edgar","filing":"0001567619-22-021571","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922021571/doc1.xml","form_type":"4"}},{"id":2104822,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-23T22:02:57.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":1887,"price":34.0653,"value":64281.2211,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":974926,"source":{"system":"sec-edgar","filing":"0001567619-22-020871","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922020871/doc1.xml","form_type":"4"}},{"id":2104821,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-23T22:02:57.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":789,"price":34.0649,"value":26877.2061,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":976813,"source":{"system":"sec-edgar","filing":"0001567619-22-020871","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922020871/doc1.xml","form_type":"4"}}],"next_cursor":"2022-11-23T22:02:57.000000Z,2104821"}